Today: 21 May 2026
Browse Category

NASDAQ:NBIS 12 November 2025 - 13 December 2025

Nebius Group NV (NBIS) Stock After Hours on Dec. 12, 2025: What Happened, Latest News, Forecasts, and What to Watch Before the Next Market Open

Nebius Group NV (NBIS) Stock After Hours on Dec. 12, 2025: What Happened, Latest News, Forecasts, and What to Watch Before the Next Market Open

Nebius Group (NASDAQ: NBIS) shares fell 6.99% to $87.69 on Dec. 12, tracking a broader selloff in AI-related stocks after cautious earnings signals from major tech firms. After-hours trading was muted, with the stock edging down to $87.38. Volume reached about 14.6 million shares. U.S. markets will reopen Monday, Dec. 15.
13 December 2025
·
Nebius Group (NBIS) Stock Drops on AI Spending Jitters: Latest News, Forecasts, and What Investors Are Watching on Dec. 12, 2025

Nebius Group (NBIS) Stock Drops on AI Spending Jitters: Latest News, Forecasts, and What Investors Are Watching on Dec. 12, 2025

Nebius Group N.V. shares fell 4.67% to $89.88 by 17:27 UTC on Dec. 12, after trading between $86.45 and $95.56. The drop followed Oracle’s results and increased 2026 capital spending, which reignited concerns about AI infrastructure profitability and triggered a broader tech selloff. Nebius recently announced a $3 billion Meta deal and a $17.4 billion Microsoft agreement.
12 December 2025
··
Nebius Group N.V. (NBIS) Stock Outlook for 2026: How Microsoft and Meta Deals Are Shaping This AI Infrastructure High‑Flier

Nebius Group N.V. (NBIS) Stock Outlook for 2026: How Microsoft and Meta Deals Are Shaping This AI Infrastructure High‑Flier

Nebius Group (NASDAQ: NBIS) traded at $97.51 on December 9, 2025, with a market cap near $25 billion, up nearly 200% this year but 31% below its 52-week high. The company signed a $17.4 billion contract with Microsoft and a $3 billion deal with Meta. Nebius remains unprofitable, burning cash and carrying significant debt. Founder control is maintained through super-voting shares.
9 December 2025
·
Nebius Group N.V. (NBIS) Stock on December 8, 2025: Latest News, Price Targets and AI Cloud Growth Forecasts

Nebius Group N.V. (NBIS) Stock on December 8, 2025: Latest News, Price Targets and AI Cloud Growth Forecasts

Nebius Group shares traded just under $100 on December 8, 2025, valuing the company in the mid-$20 billion range. Invesco and StoneX Group disclosed increased stakes, with institutions now holding about 21.9% of the float. The stock remains up over 200% year-to-date despite a 30% pullback since October. New contracts with Microsoft and Meta total over $20 billion, but Morningstar initiated coverage with a $70 fair value.
8 December 2025
··
Nebius Group N.V. (NBIS) Pre‑Market Update: What Investors Need to Know Before the December 8, 2025 Open

Nebius Group N.V. (NBIS) Pre‑Market Update: What Investors Need to Know Before the December 8, 2025 Open

Nebius Group closed at $98.04 on December 5, down 4.63%, with volume near 13 million shares. StockInvest labels it a “sell candidate,” projecting a –4.44% move over three months and high volatility. Nasdaq’s Validea model gives Nebius an 83% momentum score, while Danelfin rates it “High Risk, Hold” with a 56% chance to outperform the S&P 500.
8 December 2025
·
Nebius Group NV (NBIS) Stock on December 6, 2025: Price, Microsoft & Meta Megadeals, Q3 Results and 2026 Forecasts

Nebius Group NV (NBIS) Stock on December 6, 2025: Price, Microsoft & Meta Megadeals, Q3 Results and 2026 Forecasts

Nebius Group shares closed at $98 on December 5, down 4.6% for the day and about 30% below their 52-week high, but still over 435% above April lows. The company reported 355% year-over-year revenue growth in Q3 and signed multi-billion-dollar deals with Microsoft and Meta. Market cap stands near $25 billion, with a valuation of about 68 times trailing revenue and nearly 200 times earnings.
6 December 2025
··
Nebius Group N.V. (NBIS) Stock: 2025 AI Moonshot, Microsoft and Meta Mega-Deals, and 2026 Forecast as of December 3, 2025

Nebius Group N.V. (NBIS) Stock: 2025 AI Moonshot, Microsoft and Meta Mega-Deals, and 2026 Forecast as of December 3, 2025

Nebius Group shares traded around $97.38 midday on December 3, up about 248% year-to-date but down 30% from October highs. The company, spun off from Yandex and now focused on AI cloud infrastructure, holds a market cap near $24.5 billion. Q3 net income was –$119.6 million. Data centers operate in the U.S. and Europe, with Nvidia as a key partner.
3 December 2025
·
Nebius Stock (NBIS) on December 2, 2025: AI Mega‑Deals, 250% Rally and What Wall Street Expects Next

Nebius Stock (NBIS) on December 2, 2025: AI Mega‑Deals, 250% Rally and What Wall Street Expects Next

Nebius Group N.V. (NASDAQ: NBIS) traded just under $100 midday December 2, 2025, after surging 230–300% in the past year. The AI infrastructure firm, formerly Yandex N.V., reported a market cap near $25 billion and extreme volatility, with a 52-week range of $18.31–$141.10. Short interest stands at about 10–12% of float. Recent cloud deals with Microsoft and Meta have fueled debate on its valuation.
2 December 2025
··
Nebius Group N.V. (NBIS) Stock Ahead of December 1, 2025: Price, AI Mega‑Deals, Analyst Targets and 2026 Forecast

Nebius Group N.V. (NBIS) Stock Ahead of December 1, 2025: Price, AI Mega‑Deals, Analyst Targets and 2026 Forecast

Nebius Group closed at $94.87 on Friday, up over 240% year-to-date but still 30% below its October high. The company reported Q3 revenue of $146.1 million, with major AI-compute deals totaling up to $22 billion. Institutional investors increased stakes as analysts maintained a bullish outlook. Trading volume reached 6 million shares ahead of the 1 December U.S. market open.
30 November 2025
Nebius Stock Price Today (NBIS): Meta and Microsoft AI Deals, Q3 Earnings Shock, and 2026 Forecast – 30 November 2025

Nebius Stock Price Today (NBIS): Meta and Microsoft AI Deals, Q3 Earnings Shock, and 2026 Forecast – 30 November 2025

Nebius Group N.V. (NASDAQ: NBIS) closed at $94.87 on Nov. 28, 2025, with after-hours trading at $95.00 and a market cap near $23.9 billion. Shares have surged over 240% year-to-date but remain 30% below a recent high of $141. The company, based in Amsterdam, provides AI-focused cloud infrastructure using large NVIDIA GPU clusters. Valuations remain high, with a price-to-sales ratio around 60× trailing sales.
30 November 2025
·
Nebius Group N.V. Stock (NBIS) Today: Meta Deal, Microsoft Contract and Hedge Fund Buying – 30 November 2025 Update

Nebius Group N.V. Stock (NBIS) Today: Meta Deal, Microsoft Contract and Hedge Fund Buying – 30 November 2025 Update

Nebius Group N.V. shares have surged over 240% year-to-date but remain about 30% below their 52-week high after recent volatility. New filings show another hedge fund has started a position in the company. Nebius recently closed at $94.87, with a market cap near $24–28 billion, and its $17.4 billion AI infrastructure deal with Microsoft remains a key driver.
30 November 2025
Nebius Group N.V. (NBIS) Stock on November 29, 2025: 14% Weekly Rally, Mega AI Deals and Mounting Debt

Nebius Group N.V. (NBIS) Stock on November 29, 2025: 14% Weekly Rally, Mega AI Deals and Mounting Debt

Nebius Group shares closed Friday at $94.87, up 0.19%, after rebounding 14% this week from a sharp selloff. The stock remains about 30% below its 52-week high of $141.10 but is up roughly 242% year-to-date, with a market cap near $24 billion. Recent analyst coverage cites volatility, negative earnings, and a major Meta Platforms contract as key factors driving attention.
29 November 2025
·
Nebius Stock (NBIS) Today, November 28, 2025: Live Price, Mega AI Deals, Analyst Targets and Key Risks

Nebius Stock (NBIS) Today, November 28, 2025: Live Price, Mega AI Deals, Analyst Targets and Key Risks

Nebius Group shares traded near $94.90 midday Friday, up 0.2% from Thursday’s close but still 30% below the 52-week high. Year to date, the stock has surged over 210%. Wall Street maintains a “Strong Buy” consensus with an average price target of $164. Legal & General Group Plc cut its stake by 26.8%, while other institutions increased holdings.
28 November 2025
·
Nebius Group N.V. (NBIS) Stock Today, November 25, 2025: Price, Meta & Microsoft Deals, Analyst Targets and Fresh News

Nebius Group N.V. (NBIS) Stock Today, November 25, 2025: Price, Meta & Microsoft Deals, Analyst Targets and Fresh News

Nebius (NBIS) shares traded around $90 midday Tuesday, down 1.5–2% after a 10% surge Monday, with intraday swings between $84.70 and $91.30. New 13F filings show Steward Partners increased its stake by over 15,000% in Q2, while JPMorgan Chase nearly quadrupled its holdings. The stock remains volatile amid major contracts and heavy trading. Market cap stands near $22.7 billion.
25 November 2025
·
Nebius Group N.V. (NBIS) Stock Today, November 24, 2025: Soars Nearly 10% on Meta Deal Hype, Finland Campus Outlook and UBS Conference News

Nebius Group N.V. (NBIS) Stock Today, November 24, 2025: Soars Nearly 10% on Meta Deal Hype, Finland Campus Outlook and UBS Conference News

Nebius Group (NASDAQ: NBIS) surged nearly 10% to about $91 in late U.S. trading Monday, with volume topping 14 million shares. The rally follows new commentary on its Finland data-center campus, analyst upgrades, and an investor-relations event at the UBS Global Technology and AI Conference. The stock is rebounding from a 40% drop since October’s record high. Market cap stands just above $20 billion.
24 November 2025
·
Nebius (NBIS) Stock Rockets 350% on AI Boom – Bubble or Breakout? Experts Weigh In

Nebius (NBIS) Stock Today, 20 November 2025: After‑Hours Surge Above $100 on AI Cloud Deals and Nvidia Boost

Nebius Group shares surged in after-hours trading on 20 November 2025, reaching $103.69, up about 9% from the previous close of $95.07. The move follows Nvidia’s strong quarterly results and renewed attention on Nebius’ AI contracts and products. Trading volume on 19 November topped 21.8 million shares. The stock remains volatile, with a 52-week range of $18.31 to $141.10.
20 November 2025
····
Nebius (NBIS) Stock Rockets on $17B Microsoft AI Deal – Explosive Growth & Outlook Revealed

Nebius (NBIS) Stock Today, November 19, 2025: Jumps on Citizens Buy Rating and $3 Billion Meta AI Deal

Nebius Group shares jumped 5% to close at $95.07 Wednesday after Citizens initiated coverage with a Buy rating and $175 target. The stock traded above $100 after hours, rebounding from last week’s sharp sell-off. Nebius recently secured over $20 billion in AI infrastructure contracts, including a $3 billion Meta deal. Q3 revenue surged 355% to $146.1 million, but net loss widened to $120 million.
19 November 2025
·
Nebius (NBIS) Stock Slides After Q3 2025 Earnings: $3B Meta AI Deal, Microsoft Pact and CoreWeave Rivalry, Explained

Nebius (NBIS) Stock Slides After Q3 2025 Earnings: $3B Meta AI Deal, Microsoft Pact and CoreWeave Rivalry, Explained

Nebius shares fell about 6% to $88–$90 intraday Tuesday, extending a slide of over 30% from last month’s highs despite reporting 355% year-over-year revenue growth and a new $3 billion AI contract with Meta. Q3 revenue reached $146.1 million, but net loss widened to $119.6 million. The stock remains up more than fourfold this year. Rival CoreWeave also declined after cutting capital spending guidance.
13 November 2025
···
Nebius (NBIS) Stock Rockets 350% on AI Boom – Bubble or Breakout? Experts Weigh In

NBIS (Nebius) Stock Today — 12 November 2025: Shares Fall as Nebius Files 25M-Share ATM After $3B Meta Deal

Nebius Group shares fell about 8% to $94.13 after the company filed to sell up to 25 million Class A shares in an at-the-market equity program. The move follows Nebius’s $3 billion, five-year AI infrastructure deal with Meta and Q3 results showing revenue up 355% but continued losses. Trading volume was heavy, with shares opening at $104.35 and ranging from $91.89 to $105.53.
12 November 2025
··
1 2 3 4

Stock Market Today

  • Home Depot vs Lowe's Q1 Earnings: Contrasting Strategies Amid Housing Market Slowdown
    May 20, 2026, 6:52 PM EDT. Home Depot and Lowe's reported solid Q1 earnings, underscoring challenges in the home improvement sector amid elevated interest rates and low housing turnover. Home Depot showed a 5% sales increase to $41.76 billion but saw adjusted EPS drop to $3.43, citing cautious consumer spending and delayed large projects despite a resilient core customer base. The company focuses on professional contractor services. Lowe's posted $23.07 billion in sales with a 4% EPS rise to $3.03, emphasizing a balanced "Total Home" approach targeting pros, online, appliances, services, and DIY customers. Both reaffirmed full-year guidance amid subdued growth expectations, highlighting differing strategies to navigate housing market headwinds.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop